Compare SMTI & CMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | CMT |
|---|---|---|
| Founded | 1982 | 1996 |
| Country | United States | United States |
| Employees | N/A | 1239 |
| Industry | Medical/Dental Instruments | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.2M | 207.6M |
| IPO Year | 2008 | 1996 |
| Metric | SMTI | CMT |
|---|---|---|
| Price | $24.70 | $24.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $34.00 | $24.00 |
| AVG Volume (30 Days) | ★ 57.2K | 23.4K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.05 | ★ 0.07 |
| Revenue | $15,586,976.00 | ★ $284,290,000.00 |
| Revenue This Year | $17.31 | $4.58 |
| Revenue Next Year | $12.48 | $6.04 |
| P/E Ratio | $506.40 | ★ $353.93 |
| Revenue Growth | ★ 32.47 | 5.49 |
| 52 Week Low | $16.05 | $16.37 |
| 52 Week High | $35.70 | $28.69 |
| Indicator | SMTI | CMT |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 60.46 |
| Support Level | $20.47 | $22.74 |
| Resistance Level | $26.32 | $25.28 |
| Average True Range (ATR) | 1.47 | 0.86 |
| MACD | 0.02 | 0.17 |
| Stochastic Oscillator | 71.00 | 71.55 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.